| Sofosbuvir Basic information |
| Product Name: | Sofosbuvir |
| Synonyms: | 1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione;Sofosbuvir (PSI-7977, GS-7977);Sofosbuvir N-[[P(S),2’R]-2′-Deoxy-2′-fluoro-2′-methyl-P-phenyl-5′-uridylyl]-L-alanine 1-methylethyl ester;propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate;Suofeibuwei;Sofosbuvir, >=98%;Sofosbubir;Sofosbuvir,GS-7977 |
| CAS: | 1190307-88-0 |
| MF: | C22H29FN3O9P |
| MW: | 529.4525242 |
| EINECS: | 695-717-4 |
| Product Categories: | API;Inhibitors;Liver Disease Series;PSI7977;Pharmaceutical intermediate |
| Mol File: | 1190307-88-0.mol |
| Sofosbuvir Chemical Properties | |
| density | 1.41 |
| pka | 9.39±0.10(Predicted) |
